• 2017 - 2020 Arbeitsgruppenleiter, ReSight Consortium (Sprecher Prof. Ader), BMBF, Generation of transplantable hiPSC-derived retinal cells for treatment of retinal degeneration
• 2016 - 2017 Projekt Koordinator/ Co-PI, Singapore National Eye Centre, ACP grant, Submacular xenotransplantation of pluripotent stem cell derived RPE in monkeys
• 2016 - 2018 Projekt Koordinator/ Co-PI, Singapore National Eye Centre, HREF grant, Submacular xenotransplantation of pluripotent stem cell derived RPE in monkeys
• 2014 - 2018 Arbeitsgruppenleiter, DFG Sachmittelförderung STA 1135/2-1, Subretinal delivery and anchorage of a polyester cell carrier for retinal pigment epithelial transplantation
• 2011 - 2013 Arbeitsgruppenleiter, Gerok/ BONFOR Stipendium, Universität Bonn. Subretinale Transplantation von humanem retinalem Pigmentepithel auf einer Trägermatrix im Tiermodell
• 2008 - 2013 Arbeitsgruppenleiter, Dr. E.& H. Rüdiger Stiftung, Deutschland. Subretinale Transplantation von humanem fetalem retinalen Pigmentepithel im Kaninchen Tiermodell
• 2005 - 2006 E. Schrödinger Postdoc Stipendium, Kultivierung pigmentierter okulärer Epithelien für autologe Transplantation. Österreichischer Fonds f. wissenschaftliche Forschung (FWF J2463-B11)

• 04 / 2015 The Ophthalmologist Power List 2015: Platz 3, Top 40 under 40
• 05 / 2014 DOC Forschungspreis 2014, 27. Internationaler Kongress der Deutschen Ophthalmochirurgen
• 12 / 2013 BONFOR-Forschungspreis 2013, Medizinischen Fakultät, Universität Bonn
• 09 / 2011 Leonhard Klein Preis 2011 für Innovationen in der Augenchirurgie, Stifterverband f. d. Deutsche Wissenschaft und Deutsche Ophthalmologische Gesellschaft
• 09 / 2007 Posterpreis des 105. Kongresses der Deutschen Ophthalmologischen Gesellschaft 2007
• 2002, ‘05 & ‘06 Adele Rabensteiner Preis, Österreichische Ophthalmologische Gesellschaft

• DOG
• Retinologische Gesellschaft
• Asia and Pacific Academy of Ophthalmology
• Vail Vitrectomy Meetings 2016
• St. Christoph Vitrectomy Meetings 2015
• Association for Research in vision and ophthalmology (ARVO)

Originalarbeiten

• 1. Assadollina A, Binder S, Stanzel BV, Abri A, Krugluger W, Scholz S, Feichtinger H. Isolation von retinalen Pigmentepithelien vom nasalen Bereich der Netzhaut – eine Studie an post-mortem Bulbi. Spektrum der Augenheilkunde 2003; 17: 8-10.
• 2. Binder S, Krebs I, Hilgers RD, Abri A, Stolba U, Assadoulina A, Kellner L, Stanzel BV, Jahn C, Feichtinger H. Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: a prospective trial. Invest Ophthalmol Vis Sci 2004; 45: 4151-4160.
• 3. Stanzel BV, Espana EM, Grueterich M, Kawakita T, Parel JM, Tseng SC, Binder S. Amniotic membrane maintains the phenotype of rabbit retinal pigment epithelial cells in culture. Exp Eye Res 2005; 80: 103-112.
• 4. Rabenlehner D, Stanzel BV, Krebs I, Binder S, Goll A. Reduction of iatrogenic RPE lesions in AMD patients: evidence for wound healing? Graefes Arch Clin Exp Ophthalmol 2008; 246: 345-352.
• 5. Paulus Y, Jain A, Gariano RF, Stanzel BV, Marmor MF, Blumenkranz MS, Palanker D. Healing of Retinal Photocoagulation Lesions. Invest Ophthalmol Vis Sci 2008; 49: 5540-5545.
• 6. Stanzel BV, Suesskind D, Fimmers R, Helb HM, Eter N. Reproducibility of macular edema measurements using OCT 3 versus HRT II in neovascular AMD. Spektrum der Augenheilkunde 2009; 23: 277-282.
• 7. Milojcic C, Stanzel BV, Eter N. Long-term visual outcome after pars plana vitrectomy and ILM-Peeling with or without Indocyanine green. Spektrum der Augenheilkunde 2009; 23: 408-413. (0,089)
• 8. Thieltges F, Stanzel BV, Liu Z-P, Holz FG. A nanofibrillar surface promotes superior growth characteristics in cultured human RPE. Ophthalmic research 2011; 46: 133-40.
• 9. Stanzel BV, Liu Z, Brinken R, Braun N, Holz FG, Eter N. Subretinal Delivery of Ultrathin Rigid-Elastic Cell Carriers Using a Metallic Shooter Instrument and Biodegradable Hydrogel Encapsulation. Invest Ophthalmol Vis Sci 2012; 53: 490-500.
• 10. Aretz S, Krohne TU, Kammerer K, Warnken U, Hotz-Wagenblatt A, Bergmann M, Stanzel BV, Kempf T, Holz FG, Schnolzer M, Kopitz J. In-depth mass spectrometric mapping of the human vitreous proteome. Proteome science 2013; 11: 22-30.
• 11. Liu Z, Meyer CH, Stanzel BV. Effect of novel vital dyes on outer blood-retina barrier function in cultured human retinal pigment epithelium. Ophthalmologica 2013; 230 Suppl 2: 33-40. (1,412)
• 12. Tietjen A, Stanzel BV, Saxena S, Bezatis A, Muller M, Meyer CH. Neue Moglichkeiten der digitalen Fotodokumentation im klinischen Alltag fur Augenarzte. Klin Monbl Augenheilkd 2013; 230: 604-10.
• 13. Stanzel BV, Liu Z, Somboonthanakij S, Wongsawad W, Brinken R, Eter N, Corneo B, Holz FG, Temple S, Stern JH, Blenkinsop TA. Human RPE stem cells grown into Polarized RPE Monolayers on a Polyester Matrix are Maintained after grafting into Rabbit Subretinal Space. Stem Cell Reports 2014; 2: 64-77.
• 14. Liu Z, Na Y, Holz FG, Yang F, Stanzel BV. Enhancement of retinal pigment epithelial culture characteristics and subretinal space tolerance of scaffolds with 200 nm fiber topography. Biomaterials 2014; 35: 2837–2850
• 15. Liu Z, Meyer CH, Fimmers R, Stanzel BV. Indocyanine green concentrations used in chromovitrectomy cause a reversible functional alteration in the outer blood-retinal barrier. Acta Ophthalmol 2014; 92: e147-55.
• 16. Ilmarinen T, Hiidenmaa H, Koobi P, Nymark S, Sorkio A, Wang JH, Stanzel BV, Thieltges F, Alajuuma P, Oksala O, Kataja M, Uusitalo H, Skottman H. Ultrathin Polyimide Membrane as Cell Carrier for Subretinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigment Epithelium. PLoS ONE. 2015;10(11):e0143669.
• 17. Thieltges F, Liu Z, Brinken R, Braun N, Wongsawad W, Somboonthanakij S, Herwig MC, Holz FG, Stanzel BV. Localized RPE removal with a novel instrument aided by viscoelastics in rabbits. Transl Vis Sci Technol. 2016; 5(3):11.
• 18. Al-Nawaiseh S, Thieltges F, Liu Z, Strack C, Brinken R, Braun N, Maminishkis A, Eter N, Stanzel BV. A step by step protocol for subretinal surgery in rabbits. J Vis Exp. 2016 13;(115).
• 19. Al-Nawaiseh S, Thieltges F, Liu Z, Strack C, Brinken R, Braun N, Maminishkis A, Eter N, Stanzel BV. A step by step protocol for subretinal surgery in rabbits. J Vis Exp. 2016 Sep 13;(115).
• 20. Schulz A, Wahl S, Rickmann A, Ludwig J, Stanzel BV, von Briesen H, Szurman P. Age-Related Loss of Human Vitreal Viscoelasticity. Translational vision science & technology. 2019;8(3):56.
• 21. Sharma R, Khristov V, Rising A, Jha BS, Dejene R, Hotaling N, Li Y, Stoddard J, Stankewicz C, Wan Q, Zhang C, Campos MM, Miyagishima KJ, McGaughey D, Villasmil R, Mattapallil M, Stanzel B, Qian H, Wong W, Chase L, Charles S, McGill T, Miller S, Maminishkis A, Amaral J, Bharti K. Clinical-grade stem cell-derived retinal pigment epithelium patch rescues retinal degeneration in rodents and pigs. Sci Transl Med. 2019;11(475).
• 22. Ilmarinen T, Thieltges F, Hongisto H, Juuti-Uusitalo K, Koistinen A, Kaarniranta K, Brinken R, Braun N, Holz FG, Skottman H, Stanzel BV. Survival and functionality of xeno-free human embryonic stem cell-derived retinal pigment epithelial cells on polyester substrate after transplantation in rabbits. Acta Ophthalmol. 2019;97(5):e688-e99.
• 23. Koss MJ, Bolz M, Augustin AJ, Koch F, Szurman P, Stanzel B, Fauser S, Mennel S, Vossmerbaumer U, de Smet MD, Hohn F, Kuchle M, Lorenz B, Luke M, Lytvynchuk L, Meyer CH, Paul C, Rodrigues EB, Schrage N, Zehetner C. [Safety, Efficacy and Protective Aspects of an Add-on Paracentesis during Intravitreal Injections]. Klin Monbl Augenheilkd. 2020;237(1):90-4.
• 24. Meyer CH, Adamcova M, Rodrigues EB, Stanzel B, Koss MJ. [Closure of Persisting Full Thickness Macular Holes by Subretinal Fluid Application: Technical Approach and Surgical Considerations]. Klin Monbl Augenheilkd. 2020.
• 25. Claassen C, Dannecker M, Grubel J, Kotzampasi ME, Tovar GEM, Stanzel BV, Borchers K. The choice of biopolymer is crucial to trigger angiogenesis with vascular endothelial growth factor releasing coatings. J Mater Sci Mater Med. 2020;31(11):93
• 26. Tan GSW, Liu Z, Ilmarinen T, Barathi VA, Chee CK, Lingam G, Su X, Stanzel BV. Hints for Gentle Submacular Injection in Non-Human Primates Based on Intraoperative OCT Guidance. Transl Vis Sci Technol. 2021;10(1):10.
• 27. Liu Z, Parikh BH, Tan QSW, Wong DSL, Ong KH, Yu W, Seah I, Holder GE, Hunziker W, Tan GSW, Barathi VA, Lingam G, Stanzel BV, Blenkinsop TA, Su X. Adult-Human Retinal Pigment Epithelial Cell Transplantation Supports Retinal Function in Non-Human Primate Models. Stem Cell Reports. 2021;16(2):237-51.
• 28. Steel DH, Geraghty B, Kearns V, Stanzel B, Wong D. Subretinal injection under perfluorocarbon liquids to avoid foveal dehiscence. Retina, in Druck.

Fallberichte

• 1. Stanzel BV, Inhetvin-Hutter C, Holz FG. Diffuse Retinal Whitening Signifies Acute Retinal Necrosis. Retinal Physician 2009; http://www.retinalphysician.com/article.aspx?article=102494. (0)
• 2. Handzel DM, Stanzel BV, Briesen S. Komplikationskaskade nach hyperoper LASIK. Der Ophthalmologe 2011; 108: 665-668.
• 3. Wabbels B, Stanzel BV. [Unilateral loss of eyebrows and repeated botulinum toxin injections: questionable correlation in essential blepharospasm]. Der Ophthalmologe 2015;112(2):174-6.
• 4. Hoogmartens C, Stanzel BV. [Acute macular neuroretinopathy in a 13-year-old female patient with focal choroidal excavation and pachychoroid disease]. Der Ophthalmologe 2020;117:791-797.
• 5. Al-Nawaiseh S, Rickmann A, Stanzel BV, Szurman P, Januschowski K. [Chorioretinal folds of interesting etiology]. Der Ophthalmologe 2020;117:1234-1238.
• 6. El Mourad S, Al-Nawaiseh S, Szurman P, Stanzel BV. [Retinal capillary hemangioblastoma in the maculopapillary bundle]. Der Ophthalmologe, in Druck

Übersichtsartikel

• 1. Binder S, Stanzel BV, Krebs I, Glittenberg C. Transplantation of the RPE in AMD. Prog Retin Eye Res 2007; 26: 516-554.
• 2. Stanzel BV, Englander M, Strick DJ, Sanislo SR, Huie P, Blumenkranz MS, Binder S, Marmor MF. Perspektive: Tissue engineering bei RPE-Transplantation in AMD. Spektrum der Augenheilkunde 2007; 21: 212- 217.
• 3. Stanzel BV, Bindewald-Wittich A, Holz FG, Binder S, Eter N. Vitreoretinale Eingriffe bei fortgeschrittener altersabhängiger Makuladegeneration. Spektrum der Augenheilkunde 2008; 22: 348-356.
• 4. Helb HM, Stanzel BV, Eter N. Erhebung und Auswertung von OCT- Befunden bei Makulaerkrankungen. Klin Monbl Augenheilkd 2010; 227: R107-25; quiz R26-7. (0,35)
• 5. Stanzel BV, Meyer CH. Smartphones in der Augenheilkunde : Erleichterung oder Spielerei fur den Augenarzt? Der Ophthalmologe 2012; 109: 8-20.
• 6. Meyer CH, Stanzel BV, Moqaddem S, Brohlburg D. Apps für Smartphones im Gesundheitsbereich: Erleichterung oder Spielerei für Patienten und Sehbehinderte? Ophthalmologe 2012; 109: 21-29.
• 7. Balmer J, Stanzel BV, Fischer MD. [Stem cell therapy for retinal diseases]. Der Ophthalmologe 2015;112(9):728-37.
• 8. Stanzel BV, Gagalick A, Brinkmann CK, Brinken R, Herwig MC, Holz FG. [Intraoperative OCT in ophthalmic microsurgery]. Der Ophthalmologe. 113(5):435-42
• 9. Stanzel B, Ader M, Liu Z, Amaral J, Aguirre LIR, Rickmann A, Barathi VA, Tan GSW, Degreif A, Al-Nawaiseh S, Szurman P. Surgical Approaches for Cell Therapeutics Delivery to the Retinal Pigment Epithelium and Retina. Adv Exp Med Biol. 2019;1186:141-70.

Letters

• 1. Stanzel BV, Blumenkranz MS, Binder S,Marmor MF. Loss of culture plasticity in the human retinal pigment epithelium with aging: Implications for autologous RPE transplantation. Graefe’s archive of ophthalmology 2012; 250: 313-315.

• 2. Stanzel B, Ader M, Liu Z, Amaral J, Aguirre LIR, Rickmann A, Barathi VA, Tan GSW, Degreif A, Al-Nawaiseh S, Szurman P. Surgical Approaches for Cell Therapeutics Delivery to the Retinal Pigment Epithelium and Retina. Adv Exp   Med Biol. 2019;1186:141-70.

  3. Stanzel BV, Bindewald-Wittich A, Liu Z, Thieltges F, Holz FG, Binder S, Eter N. Chirurgische Therapie bei altersabhaengiger Makuladegeneration. In: Eter N, editor. Die altersabhaengige Makuladegeneration. 3 ed. Bremen: UNI-MED; 2013.

  4. Stanzel BV, Holz FG. Surgical strategies for AMD. In: Spaeth GL, Kampik A, editors. Ophthalmic Surgery: Principles and Practice. 4 ed. Philadelphia: Elsevier; 2012.

  5. Stanzel BV, Binder S. Current status of human retinal pigment epithelial transplantation. In: Nguyen QD, Rodriges EB, Farah ME, Mieler WF, editors. Retinal Pharmacotherapy: Elsevier; 2010.

  6. Stanzel BV, Bindewald-Wittich A, Holz FG, Binder S, Eter N. Chirurgische Therapie bei altersabhaengiger Makuladegeneration. In: Eter N, editor. Die altersabhaengige Makuladegeneration. 2 ed. Bremen: UNI-MED; 2009.

  7.  Assadoullina A, Binder S, Stanzel BV, Abri A, Krugluger W, S. S, Feichtinger H. Harvesting efficacy and viability of retinal pigment epithelial cells in aspirates from posterior retinal areas- a study on human eyes. In: Binder S, editor. The macula: Diagnosis, Treatment and Future Trends. Wien, New York: Springer; 2004. p. 45-50.

  8.  Binder S, Krebs I, Stolba U, Abri A, Feichtinger H, Hilgers RD, Kellner L, Jahn C, Assadoullina A, Stanzel BV. Transplantation of autologous retinal pigment epithelium in eyes with neovascular age-related macular degeneration. In: Binder S, editor. The macula: Diagnosis, Treatment and Future Trends. Wien, New York: Springer; 2004. p. 77-84

Patentanträge

• 1. Stanzel et al., Instrument zum subretinalen Einsetzen eines Implantats”, Europäische Patentanmeldung PCT/EP2012/058083
• 2. Stanzel et al., Instrument zur Stimulation bzw. Irritation und/oder zur Abrasivbehandlung und/oder zum Polieren einer Membran oder Oberfläche oder Innenfläche im menschlichen oder tierischen Auge“, Deutsche Patentanmeldung 10 2012 223 076.9

Eingeladene Vorträge bei internationalen Tagungen

1. “Minimal plating density required for confluence of adult human retinal pigment epithelial cells”, 2^nd International conference of vitreoretinal diseases, 9/2002, Wien
2. “Techniques for autologous RPE Transplantation”, EURETINA Joint Symposium, EVER 2003 meeting, 10/2003, Alicante/ Spanien
3. ”Kalzium moduliert das Verhalten von kultiviertem retinalem Pigmentepithel”, Augenklinik, Universitätsklinikum Eppendorf, 10/2004, Hamburg/ Deutschland
4. ”The challenge of culturing a functional RPE for autologous transplantation”, 3^rd International conference of vitreoretinal diseases, 9/2005, Wien
5. ”The challenge of culturing a functional RPE for autologous transplantation”, Grand Rounds, Dept. of Ophthalmology, University of California at San Francisco, 3/ 2006, San Francisco/ CA, USA
6. ”Fibrillar vs. Smooth: Influence of surface characteristics on cultured RPE behavior”, Retina Science Day, 3/ 2009, Wien
7. ”Tissue engineering for retinal repair”, Retinal Showcase Symposium at SOE 2009 meeting, 6/ 2009, Amsterdam/ Niederlande
8. ”Artificial basal lamina- Aguarantee for success”, 4th International conference of vitreoretinal diseases, 9/2009, Wien
9. “Tissue engineering and cellular replacement strategies of the RPE”, SOE Symposium: Cell derived therapies for retinal degeneration, World Ophthalmology Congress, 6/ 2010, Berlin/ Deutschland
10. “Scaffolds for retinal transplants”, Retinal Showcase Symposium on cell and gene therapy for retinal disease, SOE 2011 meeting, 6/ 2011, Genf/ Schweiz
11. “Spectral domain optical coherence tomography complements histologic evaluation of subretinal cell carriers for RPE transplantation”, TERMIS-EU meeting, 6/ 2011, Granada/ Spanien
12. “Tissue engineering and RPE replacement therapy”, HARVO Symposium keynote speaker, Hungarian Ophthalmological Society, 6/2011, Siofok/ Ungarn
13. “Surgical instrumentation for transvitreal subretinal delivery of retinal pigment cell monolayers cultured on an ultrathin carrier”, Shortlist candidates lecture, Innovation Award, EURETINA meeting 2012, 9/2012, Mailand/ Italien
14. “Application systems for cell-based therapies in retinal degenerations”, Stammzell-Forum, DOC Kongress, 6/2013, Nürnberg/ Deutschland
15. “Tissue engineering and basal lamina replacements”, SOE meeting, 6/2013, Kopenhagen/ Dänemark
16. ”Strategie tkanivoveho ingenierstva na vymenu alebo regeneraciu retinalneho pigment epithelia”, Keynote lecture, Jahrestreffen der Slowakischen Augenärztlichen Gesellschaft, 10/2013, Zillina, Slowakei
17. “My mSICS learning experience”, 4^th Annual Congress, Cyprus Ophthalmological Society, 11/2013, Limassol/ Zypern
18. “RPE Transplantation aided through prior tissue engineering”, 4^th Annual Congress, Cyprus Ophthalmological Society, 11/2013, Limassol/ Zypern
19. “Internet-Dschungel, mobil und fest: Wie nutze ich ophthalmologisch- relevante Inhalte?“, Augenärztliche Akademie Deutschland, 3/2014, Düsseldorf/ Deutschland
20. ” From cell culture to surgery: impact of experimental studies for the development on novel dyes”, EURETINA meeting, 9/2014, London/ Grossbritannien
21. “RPE replacement strategies”, 7^th St. Christoph meeting, 1/2015, Kleine Scheidegg/ Schweiz
22. “Why carrier scaffolds might be important for RPE-TX”, SOE meeting 2015, 6/2015, Wien
23. “Subretinal implantation of human stem cell-derived RPE on ultrathin carriers in rabbits“, EVER 2015 congress, 10/2015, Nizza/ Frankreich
24. „A new pig model for clinical translation of pluripotent stem cell derived RPE replacement“, Vail Vitrectomy Meeting, 2/ 2016, Vail/ Colorado, USA
25. „Traction retinal detachment and exudation in a teenage girl“, ASEAN Ophthalmology Meeting, 6/2016, Bangkok/ Thailand
26. „Cultured RPE implants“, Main Session/ Vitreoretinal surgery, EURETINA meeting, 9/2016, Kopenhagen/ Dänemark
27. „Latest developments in stem cell based RPE replacement therapies“, NUH 30th anniversary congress, 11/2016, Singapur
28. „Stem cell replacement in large pre-clinical model“, NUH 30th anniversary congress, 11/2016, Singapur
29. “RPE cell therapeutics for atrophic AMD: From concepts to clinical trial design”, Grand Rounds, Dept. of Ophthalmology, Stanford University, 4/2018, Palo Alto, USA
30. “Integration of submacular hESC-RPE monolayers xenografts in monkeys with a compromised blood retinal barrier”, 5^th Retinal Cell and Gene Therapy Summit, 4/2018, Honolulu, USA
31. “Transplantation von PSC/ RPE bei der geographischen Atrophie – sind wir heute einen Schritt weiter?“, DOC Kongress, 6/2018, Nürnberg/ Deutschland
32. „Hat die Zelltransplantation wieder eine Chance bei AMD?“, DOC Kongress, 6/2018, Nürnberg/ Deutschland
33. “MicroPulse Laser Induced Macular Remodeling After ILM Peeling in Full Thickness Macular Holes“, EURETINA meeting 2018, 9/2018, Wien
34. „Surgical strategies for RPE cell delivery in animal models“, ISER meeting 2018, 9/2018, Belfast, Grossbritannien
35. „Surgical macular dynamics in non-human primates by iOCT: Pearls to preserve foveal integrity“, Vail Vitrectomy Meeting, 2/ 2019, Vail/ Colorado, USA
36. „RPE cell therapeutics: How do you actually get them from the lab into a patient?“, 14th Pro Retina Research-Colloquium Potsdam˛ 3/2019, Potsdam, Deutschland
37. „Was gibt’s Neues für die Makula?“ Praxisseminar, DOC Kongress, 6/2019, Nürnberg/ Deutschland
38. “Novel developments in large eye animal models for RPE cell therapy”, 8^th St. Christoph meeting, 1/2020, Kleine Scheidegg/ Schweiz